A retrospective trend analysis examined geographical access to head and neck cancer clinical trials in the United States between 2005 and 2024 using census data and the Haversine formula. Results were published in Otolaryngology–Head and Neck Surgery. The researchers conducted a search of ClinicalTrials.gov and identified 23,450 trial sites, with 18,394 of trials beginning before 2020. Linear regression revealed a slight annual increase in trial initiation (37.947 trials/year; R²=0.014; P=0.625), but most observed trends did not reach statistical significance. ...
Oncology
Advertisement
The main features of intestinal inflammation are reproduced as a biomarker for response to immune checkpoint inhibition.
There was a 29% increase in cancer detection with AI-supported screening.
Researchers found two effective treatments for metaplastic breast cancer.
Subgroup analyses of multiple diagnostic performance metrics in high vs low-income communities were also performed.
New research has uncovered a combination therapy that shows promising results in melanoma and breast cancer models.
A study compared the screening performances of a tools used in cervical cancer screening in HIV-positive women.
Aliya Omer, AstraZeneca, talks about data that backs the efficacy of olaparib in treating high-risk early breast cancer.
Results were deduced from self-collected as well as clinician-obtained screening results.
In patients with high-risk HER2-psoitive breast cancer, adjuvant trastuzumab emtansine reduces the long-term risk of death.
A recent study shows that macrophages can be used to predict whether or not a melanoma patient will respond to chemotherapy.
Advertisement
Expert Interviews on Oncology
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.